Malignant pleural mesothelioma: a comprehensive review.
BACKGROUND
The incidence of malignant mesothelioma continues to increase, but the disease remains difficult to detect early and treat effectively.


METHODS
The authors review the pathogenesis, incidence, clinical presentation, diagnosis, pathology, and both standard and experimental treatments for mesothelioma.


RESULTS
When possible, surgery (video-assisted thoracoscopy, pleurectomy/decortication, or extrapleural pneumonectomy) is utilized. Effects on underlying structures limit application of radiation therapy, but some systemic agents are beginning to enhance survival.


CONCLUSIONS
The disease is expected to increase in incidence till 2020, so awareness of this entity as a possible diagnosis should be heightened. In patients with advanced disease, several newer antitumor agents are already showing a capability of extending survival so it is not unreasonable to expect further progress in this area.
Ismail-Khan
Roohi
R
Thoracic Oncology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Robinson
Lary A
LA
Williams
Charles C
CC
Garrett
Christopher R
CR
Bepler
Gerold
G
Simon
George R
GR
D006801:Humans; D015994:Incidence; D008279:Magnetic Resonance Imaging; D008654:Mesothelioma / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D009367:Neoplasm Staging; D016066:Pleural Effusion, Malignant / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D010997:Pleural Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D014057:Tomography, X-Ray Computed; D014481:United States / Q000453:epidemiology